Trademark Overview
On Tuesday, May 26, 2026, a trademark application was filed for HYAGENIX with the United States Patent and Trademark Office. The USPTO has given the HYAGENIX trademark a serial number of 99846496. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 26, 2026. This trademark is owned by EIRGENIX, INC.. The HYAGENIX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Research and development services in the field of biotechnology; Scientific research and development; Scientific laboratory services; Scientific investigations for medical purposes; Technological research in the field of pharmaceutical research and development, pharmaceutical drug delivery systems, recombinant hyaluronidase, enzyme technologies, biopharmaceutical development, and platform-based biotechnology research services; Scientific research; Research and development of new products for others; Chemical research; Medical research; Development of pharmaceutical preparations and medicines; Medical and scientific research, namely, conducting clinical trials for others; Biological research
Drug delivery agents in the form of injectable pharmaceutical preparations for subcutaneous administration that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for facilitating the subcutaneous delivery of pharmaceutical preparations, namely, recombinant hyaluronidase preparations and enzyme-based pharmaceutical preparations; Enzymes for medical purposes; Enzyme preparations for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for facilitating the subcutaneous delivery of pharmaceutical preparations;; Adjuvants for medical purposes; Vaccines; Enzyme preparations for veterinary purposes
